> top > docs > PubMed:25550469 > annotations

PubMed:25550469 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 115-119 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T3 338-342 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T5 383-387 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T7 615-619 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T9 934-938 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T11 957-961 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T13 1255-1259 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088
T15 1503-1507 OrganismTaxon denotes mice NCBItxid:10095|NCBItxid:10088

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T5 642-846 Sentence denotes They also displayed increased body weight (+18%), body fat percentage (+62%), and hepatic triglyceride levels, reduced insulin sensitivity, and a marked atherogenic dyslipidemia (serum cholesterol, +52%).
T1 0-120 Sentence denotes The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice.
T2 121-227 Sentence denotes Androgens have important cardiometabolic actions in males, but their metabolic role in females is unclear.
T3 228-461 Sentence denotes To determine the physiologic androgen receptor (AR)-dependent actions of androgens on atherogenesis in female mice, we generated female AR-knockout (ARKO) mice on an atherosclerosis-prone apolipoprotein E (apoE)-deficient background.
T4 462-641 Sentence denotes After 8 weeks on a high-fat diet, but not on a normal chow diet, atherosclerosis in aorta was increased in ARKO females (+59% vs. control apoE-deficient mice with intact AR gene).
T6 847-1080 Sentence denotes Differences in atherosclerosis, body weight, and lipid levels between ARKO and control mice were abolished in mice that were ovariectomized before puberty, consistent with a protective action of ovarian androgens mediated via the AR.
T7 1081-1404 Sentence denotes Furthermore, the AR agonist dihydrotestosterone reduced atherosclerosis (-41%; thoracic aorta), subcutaneous fat mass (-44%), and cholesterol levels (-35%) in ovariectomized mice, reduced hepatocyte lipid accumulation in hepatoma cells in vitro, and regulated mRNA expression of hepatic genes pivotal for lipid homeostasis.
T8 1405-1597 Sentence denotes In conclusion, we demonstrate that the AR protects against diet-induced atherosclerosis in female mice and propose that this is mediated by modulation of body composition and lipid metabolism.

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
10383 4-21 GeneOrGeneProduct denotes androgen receptor NCBIGene:11835
10384 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis MESH:D050197
10385 79-86 DiseaseOrPhenotypicFeature denotes obesity MESH:D009765
10386 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia MESH:D050171
10387 115-119 OrganismTaxon denotes mice NCBITaxon:10090
10388 121-130 ChemicalEntity denotes Androgens MESH:D000728
10389 257-274 GeneOrGeneProduct denotes androgen receptor NCBIGene:11835
10390 276-278 GeneOrGeneProduct denotes AR NCBIGene:11835
10391 301-310 ChemicalEntity denotes androgens MESH:D000728
10392 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis MESH:D050197
10393 338-342 OrganismTaxon denotes mice NCBITaxon:10090
10394 364-366 GeneOrGeneProduct denotes AR NCBIGene:11835
10395 377-379 GeneOrGeneProduct denotes AR NCBIGene:11835
10396 383-387 OrganismTaxon denotes mice NCBITaxon:10090
10397 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis MESH:D050197
10398 416-432 GeneOrGeneProduct denotes apolipoprotein E NCBIGene:11816
10399 434-438 GeneOrGeneProduct denotes apoE NCBIGene:11816
10400 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis MESH:D050197
10401 569-571 GeneOrGeneProduct denotes AR NCBIGene:11835
10402 600-604 GeneOrGeneProduct denotes apoE NCBIGene:11816
10403 615-619 OrganismTaxon denotes mice NCBITaxon:10090
10404 632-634 GeneOrGeneProduct denotes AR NCBIGene:11835
10405 732-744 GeneOrGeneProduct denotes triglyceride NCBIGene:100035834
10406 761-768 GeneOrGeneProduct denotes insulin NCBIGene:16334
10407 795-806 DiseaseOrPhenotypicFeature denotes atherogenic MESH:D050197
10408 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia MESH:D050171
10409 827-838 ChemicalEntity denotes cholesterol MESH:D002784
10410 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis MESH:D050197
10411 896-901 ChemicalEntity denotes lipid MESH:D008055
10412 917-919 GeneOrGeneProduct denotes AR NCBIGene:11835
10413 934-938 OrganismTaxon denotes mice NCBITaxon:10090
10414 957-961 OrganismTaxon denotes mice NCBITaxon:10090
10415 1050-1059 ChemicalEntity denotes androgens MESH:D000728
10416 1077-1079 GeneOrGeneProduct denotes AR NCBIGene:11835
10417 1098-1100 GeneOrGeneProduct denotes AR NCBIGene:11835
10418 1109-1128 ChemicalEntity denotes dihydrotestosterone MESH:D013196
10419 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis MESH:D050197
10420 1211-1222 ChemicalEntity denotes cholesterol MESH:D002784
10421 1255-1259 OrganismTaxon denotes mice NCBITaxon:10090
10422 1280-1285 ChemicalEntity denotes lipid MESH:D008055
10423 1302-1310 DiseaseOrPhenotypicFeature denotes hepatoma MESH:D006528
10424 1386-1391 ChemicalEntity denotes lipid MESH:D008055
10425 1444-1446 GeneOrGeneProduct denotes AR NCBIGene:11835
10426 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis MESH:D050197
10427 1503-1507 OrganismTaxon denotes mice NCBITaxon:10090
10428 1580-1585 ChemicalEntity denotes lipid MESH:D008055

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T2 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T3 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T4 724-731 DiseaseOrPhenotypicFeature denotes hepatic 0002251
T5 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T6 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T7 1360-1367 DiseaseOrPhenotypicFeature denotes hepatic 0002251
T8 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 219-226 GeneOrGeneProduct denotes unclear
T3 257-274 GeneOrGeneProduct denotes androgen receptor
T4 276-278 GeneOrGeneProduct denotes AR
T5 364-366 GeneOrGeneProduct denotes AR
T6 367-375 GeneOrGeneProduct denotes knockout
T7 416-432 GeneOrGeneProduct denotes apolipoprotein E
T8 434-438 GeneOrGeneProduct denotes apoE
T9 481-485 GeneOrGeneProduct denotes high
T10 600-604 GeneOrGeneProduct denotes apoE
T11 632-634 GeneOrGeneProduct denotes AR
T12 672-683 GeneOrGeneProduct denotes body weight
T13 697-711 GeneOrGeneProduct denotes fat percentage
T14 732-751 GeneOrGeneProduct denotes triglyceride levels
T15 753-760 GeneOrGeneProduct denotes reduced
T16 761-768 GeneOrGeneProduct denotes insulin
T17 879-890 GeneOrGeneProduct denotes body weight
T18 1077-1079 GeneOrGeneProduct denotes AR
T19 1098-1100 GeneOrGeneProduct denotes AR
T20 1129-1136 GeneOrGeneProduct denotes reduced
T21 1177-1193 GeneOrGeneProduct denotes subcutaneous fat
T22 1211-1229 GeneOrGeneProduct denotes cholesterol levels
T23 1261-1268 GeneOrGeneProduct denotes reduced
T24 1341-1345 GeneOrGeneProduct denotes mRNA
T25 1444-1446 GeneOrGeneProduct denotes AR

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 54-61 GeneOrGeneProduct denotes induced
T3 79-86 GeneOrGeneProduct denotes obesity
T4 115-119 GeneOrGeneProduct denotes mice
T5 173-178 GeneOrGeneProduct denotes males
T6 219-226 GeneOrGeneProduct denotes unclear
T7 231-240 GeneOrGeneProduct denotes determine
T8 257-274 GeneOrGeneProduct denotes androgen receptor
T9 276-278 GeneOrGeneProduct denotes AR
T10 338-342 GeneOrGeneProduct denotes mice
T11 364-366 GeneOrGeneProduct denotes AR
T12 367-375 GeneOrGeneProduct denotes knockout
T13 377-381 GeneOrGeneProduct denotes ARKO
T14 383-387 GeneOrGeneProduct denotes mice
T15 416-432 GeneOrGeneProduct denotes apolipoprotein E
T16 434-438 GeneOrGeneProduct denotes apoE
T17 481-485 GeneOrGeneProduct denotes high
T18 500-508 GeneOrGeneProduct denotes not on a
T19 516-520 GeneOrGeneProduct denotes chow
T20 569-573 GeneOrGeneProduct denotes ARKO
T21 600-604 GeneOrGeneProduct denotes apoE
T22 615-619 GeneOrGeneProduct denotes mice
T23 632-634 GeneOrGeneProduct denotes AR
T24 672-683 GeneOrGeneProduct denotes body weight
T25 697-711 GeneOrGeneProduct denotes fat percentage
T26 732-751 GeneOrGeneProduct denotes triglyceride levels
T27 753-760 GeneOrGeneProduct denotes reduced
T28 761-768 GeneOrGeneProduct denotes insulin
T29 788-794 GeneOrGeneProduct denotes marked
T30 879-890 GeneOrGeneProduct denotes body weight
T31 917-921 GeneOrGeneProduct denotes ARKO
T32 934-938 GeneOrGeneProduct denotes mice
T33 957-961 GeneOrGeneProduct denotes mice
T34 1060-1068 GeneOrGeneProduct denotes mediated
T35 1077-1079 GeneOrGeneProduct denotes AR
T36 1098-1100 GeneOrGeneProduct denotes AR
T37 1129-1136 GeneOrGeneProduct denotes reduced
T38 1177-1193 GeneOrGeneProduct denotes subcutaneous fat
T39 1194-1198 GeneOrGeneProduct denotes mass
T40 1211-1229 GeneOrGeneProduct denotes cholesterol levels
T41 1255-1259 GeneOrGeneProduct denotes mice
T42 1261-1268 GeneOrGeneProduct denotes reduced
T43 1311-1316 GeneOrGeneProduct denotes cells
T44 1331-1340 GeneOrGeneProduct denotes regulated
T45 1341-1345 GeneOrGeneProduct denotes mRNA
T46 1374-1385 GeneOrGeneProduct denotes pivotal for
T47 1444-1446 GeneOrGeneProduct denotes AR
T48 1469-1476 GeneOrGeneProduct denotes induced
T49 1503-1507 GeneOrGeneProduct denotes mice
T50 1533-1541 GeneOrGeneProduct denotes mediated

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 4-12 DiseaseOrPhenotypicFeature denotes androgen D014770
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity D009765
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia D050171
T5 257-265 DiseaseOrPhenotypicFeature denotes androgen D014770
T6 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis D050197
T7 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T8 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T9 672-683 DiseaseOrPhenotypicFeature denotes body weight D001835
T10 761-780 DiseaseOrPhenotypicFeature denotes insulin sensitivity D007333
T11 795-806 DiseaseOrPhenotypicFeature denotes atherogenic DISEASE
T12 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia D050171
T13 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T14 879-890 DiseaseOrPhenotypicFeature denotes body weight D001835
T15 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T16 1302-1310 DiseaseOrPhenotypicFeature denotes hepatoma D006528
T17 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 257-274 GeneOrGeneProduct denotes androgen receptor
T3 276-278 GeneOrGeneProduct denotes AR
T4 364-366 GeneOrGeneProduct denotes AR
T5 416-432 GeneOrGeneProduct denotes apolipoprotein E
T6 434-438 GeneOrGeneProduct denotes apoE
T7 600-604 GeneOrGeneProduct denotes apoE
T8 632-634 GeneOrGeneProduct denotes AR
T9 697-711 GeneOrGeneProduct denotes fat percentage
T10 732-751 GeneOrGeneProduct denotes triglyceride levels
T11 1077-1079 GeneOrGeneProduct denotes AR
T12 1098-1100 GeneOrGeneProduct denotes AR
T13 1177-1193 GeneOrGeneProduct denotes subcutaneous fat
T14 1211-1229 GeneOrGeneProduct denotes cholesterol levels
T15 1444-1446 GeneOrGeneProduct denotes AR

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T2 79-86 DiseaseOrPhenotypicFeature denotes obesity 0011122
T3 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia 0002525
T4 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T5 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T6 769-780 DiseaseOrPhenotypicFeature denotes sensitivity 0000605
T7 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia 0002525
T8 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T9 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311
T10 1302-1310 DiseaseOrPhenotypicFeature denotes hepatoma 0007256
T11 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis 0005311

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T2 79-86 DiseaseOrPhenotypicFeature denotes obesity D009765
T3 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia D050171
T4 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis D050197
T5 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T6 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T7 672-683 DiseaseOrPhenotypicFeature denotes body weight D001835
T8 761-780 DiseaseOrPhenotypicFeature denotes insulin sensitivity D007333
T9 795-806 DiseaseOrPhenotypicFeature denotes atherogenic DISEASE
T10 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia D050171
T11 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T12 879-890 DiseaseOrPhenotypicFeature denotes body weight D001835
T13 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T14 1302-1310 DiseaseOrPhenotypicFeature denotes hepatoma D006528
T15 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T2 79-86 DiseaseOrPhenotypicFeature denotes obesity D009765
T3 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia D050171
T4 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis D050197
T5 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T6 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T7 795-806 DiseaseOrPhenotypicFeature denotes atherogenic DISEASE
T8 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia D050171
T9 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T10 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T11 1302-1310 DiseaseOrPhenotypicFeature denotes hepatoma D006528
T12 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T1 4-12 ChemicalEntity denotes androgen ChemicalEntity
T2 121-130 ChemicalEntity denotes Androgens ChemicalEntity
T3 257-265 ChemicalEntity denotes androgen ChemicalEntity
T4 301-310 ChemicalEntity denotes androgens ChemicalEntity
T5 416-430 ChemicalEntity denotes apolipoprotein http://purl.obolibrary.org/obo/CHEBI_39015
T6 732-744 ChemicalEntity denotes triglyceride D014280|http://purl.obolibrary.org/obo/CHEBI_17855
T8 827-838 ChemicalEntity denotes cholesterol D002784|http://purl.obolibrary.org/obo/CHEBI_16113
T10 1050-1059 ChemicalEntity denotes androgens ChemicalEntity
T11 1109-1128 ChemicalEntity denotes dihydrotestosterone D013196|http://purl.obolibrary.org/obo/CHEBI_85278|http://purl.obolibrary.org/obo/CHEBI_16330
T14 1211-1222 ChemicalEntity denotes cholesterol D002784|http://purl.obolibrary.org/obo/CHEBI_16113

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 115-119 OrganismTaxon denotes mice
T2 338-342 OrganismTaxon denotes mice
T3 383-387 OrganismTaxon denotes mice
T4 615-619 OrganismTaxon denotes mice
T5 934-938 OrganismTaxon denotes mice
T6 957-961 OrganismTaxon denotes mice
T7 1255-1259 OrganismTaxon denotes mice
T8 1503-1507 OrganismTaxon denotes mice

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T14 1211-1222 ChemicalEntity denotes cholesterol http://purl.obolibrary.org/obo/CHEBI_16113|D002784
T11 1109-1128 ChemicalEntity denotes dihydrotestosterone http://purl.obolibrary.org/obo/CHEBI_16330|http://purl.obolibrary.org/obo/CHEBI_85278|D013196
T10 1050-1059 ChemicalEntity denotes androgens ChemicalEntity
T8 827-838 ChemicalEntity denotes cholesterol http://purl.obolibrary.org/obo/CHEBI_16113|D002784
T6 732-744 ChemicalEntity denotes triglyceride http://purl.obolibrary.org/obo/CHEBI_17855|D014280
T5 416-430 ChemicalEntity denotes apolipoprotein http://purl.obolibrary.org/obo/CHEBI_39015
T4 301-310 ChemicalEntity denotes androgens ChemicalEntity
T3 257-265 ChemicalEntity denotes androgen ChemicalEntity
T2 121-130 ChemicalEntity denotes Androgens ChemicalEntity
T1 4-12 ChemicalEntity denotes androgen ChemicalEntity
T15 1444-1446 GeneOrGeneProduct denotes AR
T19803 1211-1229 GeneOrGeneProduct denotes cholesterol levels
T13 1177-1193 GeneOrGeneProduct denotes subcutaneous fat
T12 1098-1100 GeneOrGeneProduct denotes AR
T44633 1077-1079 GeneOrGeneProduct denotes AR
T88675 732-751 GeneOrGeneProduct denotes triglyceride levels
T9 697-711 GeneOrGeneProduct denotes fat percentage
T16030 632-634 GeneOrGeneProduct denotes AR
T7 600-604 GeneOrGeneProduct denotes apoE
T36503 434-438 GeneOrGeneProduct denotes apoE
T98345 416-432 GeneOrGeneProduct denotes apolipoprotein E
T9491 364-366 GeneOrGeneProduct denotes AR
T96601 276-278 GeneOrGeneProduct denotes AR
T10938 257-274 GeneOrGeneProduct denotes androgen receptor
T42446 4-21 GeneOrGeneProduct denotes androgen receptor
T76302 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T62725 1302-1310 DiseaseOrPhenotypicFeature denotes hepatoma D006528
T73714 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T65387 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T57706 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia D050171
T84426 795-806 DiseaseOrPhenotypicFeature denotes atherogenic DISEASE
T47918 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T27464 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T314 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis D050197
T11297 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia D050171
T88541 79-86 DiseaseOrPhenotypicFeature denotes obesity D009765
T36453 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis D050197
T11206 1503-1507 OrganismTaxon denotes mice
T83842 1255-1259 OrganismTaxon denotes mice
T99373 957-961 OrganismTaxon denotes mice
T311 934-938 OrganismTaxon denotes mice
T17422 615-619 OrganismTaxon denotes mice
T83221 383-387 OrganismTaxon denotes mice
T11178 338-342 OrganismTaxon denotes mice
T15025 115-119 OrganismTaxon denotes mice

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 394-409 HP_0002621 denotes atherosclerosis
T2 527-542 HP_0002621 denotes atherosclerosis
T3 527-551 HP_0012397 denotes atherosclerosis in aorta
T4 662-683 HP_0004324 denotes increased body weight
T5 862-877 HP_0002621 denotes atherosclerosis
T6 1137-1152 HP_0002621 denotes atherosclerosis
T7 1269-1298 HP_0006561 denotes hepatocyte lipid accumulation
T8 1477-1492 HP_0002621 denotes atherosclerosis

biored-valid-deepseek-nr-ng

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 108-114 OrganismTaxon denotes female
T6 115-119 OrganismTaxon denotes mice
T7 121-130 ChemicalEntity denotes Androgens
T8 173-178 OrganismTaxon denotes males
T9 208-215 OrganismTaxon denotes females
T10 257-274 GeneOrGeneProduct denotes androgen receptor
T11 276-278 GeneOrGeneProduct denotes AR
T12 331-337 OrganismTaxon denotes female
T13 338-342 OrganismTaxon denotes mice
T14 364-375 SequenceVariant denotes AR-knockout
T15 377-381 SequenceVariant denotes ARKO
T16 383-387 OrganismTaxon denotes mice
T17 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T18 416-432 GeneOrGeneProduct denotes apolipoprotein E
T19 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T20 546-551 DiseaseOrPhenotypicFeature denotes aorta
T21 569-571 GeneOrGeneProduct denotes AR
T22 574-581 OrganismTaxon denotes females
T23 600-614 SequenceVariant denotes apoE-deficient
T24 615-619 OrganismTaxon denotes mice
T25 632-634 GeneOrGeneProduct denotes AR
T26 635-639 GeneOrGeneProduct denotes gene
T27 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia
T28 827-838 ChemicalEntity denotes cholesterol
T29 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T30 934-938 OrganismTaxon denotes mice
T31 957-961 OrganismTaxon denotes mice
T32 1050-1059 ChemicalEntity denotes androgens
T33 1109-1128 ChemicalEntity denotes dihydrotestosterone
T34 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T35 1160-1174 DiseaseOrPhenotypicFeature denotes thoracic aorta
T36 1211-1222 ChemicalEntity denotes cholesterol
T37 1302-1316 CellLine denotes hepatoma cells
T38 1341-1345 GeneOrGeneProduct denotes mRNA

biored-valid

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 115-119 OrganismTaxon denotes mice
T6 121-130 ChemicalEntity denotes Androgens
T7 257-274 GeneOrGeneProduct denotes androgen receptor
T8 276-278 GeneOrGeneProduct denotes AR
T9 301-310 ChemicalEntity denotes androgens
T10 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis
T11 338-342 OrganismTaxon denotes mice
T12 364-366 GeneOrGeneProduct denotes AR
T13 377-379 GeneOrGeneProduct denotes AR
T14 383-387 OrganismTaxon denotes mice
T15 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T16 416-432 GeneOrGeneProduct denotes apolipoprotein E
T17 434-438 GeneOrGeneProduct denotes apoE
T18 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T19 569-571 GeneOrGeneProduct denotes AR
T20 600-604 GeneOrGeneProduct denotes apoE
T21 615-619 OrganismTaxon denotes mice
T22 632-634 GeneOrGeneProduct denotes AR
T23 732-744 GeneOrGeneProduct denotes triglyceride
T24 761-768 GeneOrGeneProduct denotes insulin
T25 795-806 DiseaseOrPhenotypicFeature denotes atherogenic
T26 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia
T27 827-838 ChemicalEntity denotes cholesterol
T28 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T29 896-901 ChemicalEntity denotes lipid
T30 917-919 GeneOrGeneProduct denotes AR
T31 934-938 OrganismTaxon denotes mice
T32 957-961 OrganismTaxon denotes mice
T33 1050-1059 ChemicalEntity denotes androgens
T34 1077-1079 GeneOrGeneProduct denotes AR
T35 1098-1100 GeneOrGeneProduct denotes AR
T36 1109-1128 ChemicalEntity denotes dihydrotestosterone
T37 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T38 1211-1222 ChemicalEntity denotes cholesterol
T39 1255-1259 OrganismTaxon denotes mice
T40 1280-1285 ChemicalEntity denotes lipid
T41 1302-1310 DiseaseOrPhenotypicFeature denotes hepatoma
T42 1386-1391 ChemicalEntity denotes lipid
T43 1444-1446 GeneOrGeneProduct denotes AR
T44 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis
T45 1503-1507 OrganismTaxon denotes mice
T46 1580-1585 ChemicalEntity denotes lipid

biored-valid-deepseek-nr-g

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 108-119 OrganismTaxon denotes female mice
T6 121-130 ChemicalEntity denotes Androgens
T7 208-215 OrganismTaxon denotes females
T8 257-274 GeneOrGeneProduct denotes androgen receptor
T9 276-278 GeneOrGeneProduct denotes AR
T10 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis
T11 331-342 OrganismTaxon denotes female mice
T12 364-375 SequenceVariant denotes AR-knockout
T13 377-381 SequenceVariant denotes ARKO
T14 383-387 OrganismTaxon denotes mice
T15 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T16 434-438 GeneOrGeneProduct denotes apoE
T17 440-449 DiseaseOrPhenotypicFeature denotes deficient
T18 481-494 ChemicalEntity denotes high-fat diet
T19 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T20 546-551 DiseaseOrPhenotypicFeature denotes aorta
T21 569-571 GeneOrGeneProduct denotes AR
T22 574-581 OrganismTaxon denotes females
T23 615-619 OrganismTaxon denotes mice
T24 635-639 GeneOrGeneProduct denotes gene
T25 672-683 DiseaseOrPhenotypicFeature denotes body weight
T26 692-700 DiseaseOrPhenotypicFeature denotes body fat
T27 724-744 ChemicalEntity denotes hepatic triglyceride
T28 761-780 DiseaseOrPhenotypicFeature denotes insulin sensitivity
T29 795-819 DiseaseOrPhenotypicFeature denotes atherogenic dyslipidemia
T30 821-838 ChemicalEntity denotes serum cholesterol
T31 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T32 896-908 ChemicalEntity denotes lipid levels
T33 917-919 GeneOrGeneProduct denotes AR
T34 934-938 OrganismTaxon denotes mice
T35 972-986 DiseaseOrPhenotypicFeature denotes ovariectomized
T36 1042-1049 OrganismTaxon denotes ovarian
T37 1050-1059 ChemicalEntity denotes androgens
T38 1077-1079 GeneOrGeneProduct denotes AR
T39 1101-1108 ChemicalEntity denotes agonist
T40 1109-1128 ChemicalEntity denotes dihydrotestosterone
T41 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T42 1160-1174 DiseaseOrPhenotypicFeature denotes thoracic aorta
T43 1177-1198 DiseaseOrPhenotypicFeature denotes subcutaneous fat mass
T44 1211-1229 ChemicalEntity denotes cholesterol levels
T45 1269-1285 ChemicalEntity denotes hepatocyte lipid
T46 1302-1316 CellLine denotes hepatoma cells
T47 1341-1345 GeneOrGeneProduct denotes mRNA
T48 1368-1373 GeneOrGeneProduct denotes genes
T49 1386-1403 ChemicalEntity denotes lipid homeostasis
T50 1496-1507 OrganismTaxon denotes female mice
T51 1559-1575 DiseaseOrPhenotypicFeature denotes body composition
T52 1580-1596 ChemicalEntity denotes lipid metabolism

biored-valid-deepseek-r-ng

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 108-119 OrganismTaxon denotes female mice
T6 121-130 ChemicalEntity denotes Androgens
T7 276-278 GeneOrGeneProduct denotes AR
T8 364-375 SequenceVariant denotes AR-knockout
T9 377-381 SequenceVariant denotes ARKO
T10 416-432 GeneOrGeneProduct denotes apolipoprotein E
T11 434-438 GeneOrGeneProduct denotes apoE
T12 600-614 DiseaseOrPhenotypicFeature denotes apoE-deficient
T13 672-683 DiseaseOrPhenotypicFeature denotes body weight
T14 692-711 DiseaseOrPhenotypicFeature denotes body fat percentage
T15 732-744 ChemicalEntity denotes triglyceride
T16 761-780 DiseaseOrPhenotypicFeature denotes insulin sensitivity
T17 795-819 DiseaseOrPhenotypicFeature denotes atherogenic dyslipidemia
T18 827-838 ChemicalEntity denotes cholesterol
T19 1042-1059 ChemicalEntity denotes ovarian androgens
T20 1109-1128 ChemicalEntity denotes dihydrotestosterone
T21 1302-1316 CellLine denotes hepatoma cells
T22 1360-1373 GeneOrGeneProduct denotes hepatic genes
T23 1580-1596 DiseaseOrPhenotypicFeature denotes lipid metabolism

biored-valid-deepseek-r-g

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 121-130 ChemicalEntity denotes Androgens
T6 276-278 GeneOrGeneProduct denotes AR
T7 338-342 OrganismTaxon denotes mice
T8 364-375 SequenceVariant denotes AR-knockout
T9 377-381 SequenceVariant denotes ARKO
T10 416-432 GeneOrGeneProduct denotes apolipoprotein E
T11 434-438 GeneOrGeneProduct denotes apoE
T12 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T13 569-573 SequenceVariant denotes ARKO
T14 600-614 SequenceVariant denotes apoE-deficient
T15 632-634 GeneOrGeneProduct denotes AR
T16 732-744 ChemicalEntity denotes triglyceride
T17 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia
T18 827-838 ChemicalEntity denotes cholesterol
T19 917-921 SequenceVariant denotes ARKO
T20 1050-1059 ChemicalEntity denotes androgens
T21 1077-1079 GeneOrGeneProduct denotes AR
T22 1109-1128 ChemicalEntity denotes dihydrotestosterone
T23 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T24 1211-1222 ChemicalEntity denotes cholesterol
T25 1255-1259 OrganismTaxon denotes mice
T26 1302-1316 CellLine denotes hepatoma cells
T27 1444-1446 GeneOrGeneProduct denotes AR
T28 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis
T29 1503-1507 OrganismTaxon denotes mice

biored-valid-gemini-nr-ng

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 108-119 OrganismTaxon denotes female mice
T6 121-130 ChemicalEntity denotes Androgens
T7 173-178 OrganismTaxon denotes males
T8 208-215 OrganismTaxon denotes females
T9 257-274 GeneOrGeneProduct denotes androgen receptor
T10 276-278 GeneOrGeneProduct denotes AR
T11 301-310 ChemicalEntity denotes androgens
T12 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis
T13 331-342 OrganismTaxon denotes female mice
T14 364-366 GeneOrGeneProduct denotes AR
T15 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T16 416-449 SequenceVariant denotes apolipoprotein E (apoE)-deficient
T17 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T18 569-571 GeneOrGeneProduct denotes AR
T19 592-619 OrganismTaxon denotes control apoE-deficient mice
T20 635-639 GeneOrGeneProduct denotes gene
T21 732-744 ChemicalEntity denotes triglyceride
T22 795-819 DiseaseOrPhenotypicFeature denotes atherogenic dyslipidemia
T23 821-838 ChemicalEntity denotes serum cholesterol
T24 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T25 917-919 GeneOrGeneProduct denotes AR
T26 934-938 OrganismTaxon denotes mice
T27 957-961 OrganismTaxon denotes mice
T28 1042-1059 ChemicalEntity denotes ovarian androgens
T29 1098-1100 GeneOrGeneProduct denotes AR
T30 1109-1128 ChemicalEntity denotes dihydrotestosterone
T31 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T32 1211-1222 ChemicalEntity denotes cholesterol
T33 1302-1316 CellLine denotes hepatoma cells
T34 1496-1507 OrganismTaxon denotes female mice

biored-valid-gemini-r-ng

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 115-119 OrganismTaxon denotes mice
T6 121-130 ChemicalEntity denotes Androgens
T7 257-274 GeneOrGeneProduct denotes androgen receptor
T8 276-278 GeneOrGeneProduct denotes AR
T9 301-310 ChemicalEntity denotes androgens
T10 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis
T11 331-342 OrganismTaxon denotes female mice
T12 364-375 SequenceVariant denotes AR-knockout
T13 377-381 SequenceVariant denotes ARKO
T14 394-415 DiseaseOrPhenotypicFeature denotes atherosclerosis-prone
T15 416-432 GeneOrGeneProduct denotes apolipoprotein E
T16 434-438 GeneOrGeneProduct denotes apoE
T17 439-449 SequenceVariant denotes -deficient
T18 569-573 SequenceVariant denotes ARKO
T19 600-614 SequenceVariant denotes apoE-deficient
T20 615-619 OrganismTaxon denotes mice
T21 632-639 GeneOrGeneProduct denotes AR gene
T22 662-683 DiseaseOrPhenotypicFeature denotes increased body weight
T23 692-711 DiseaseOrPhenotypicFeature denotes body fat percentage
T24 724-751 DiseaseOrPhenotypicFeature denotes hepatic triglyceride levels
T25 753-780 DiseaseOrPhenotypicFeature denotes reduced insulin sensitivity
T26 795-819 DiseaseOrPhenotypicFeature denotes atherogenic dyslipidemia
T27 821-838 DiseaseOrPhenotypicFeature denotes serum cholesterol
T28 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T29 879-890 DiseaseOrPhenotypicFeature denotes body weight
T30 896-908 DiseaseOrPhenotypicFeature denotes lipid levels
T31 917-921 SequenceVariant denotes ARKO
T32 926-938 OrganismTaxon denotes control mice
T33 972-986 DiseaseOrPhenotypicFeature denotes ovariectomized
T34 1050-1059 ChemicalEntity denotes androgens
T35 1098-1108 ChemicalEntity denotes AR agonist
T36 1109-1128 ChemicalEntity denotes dihydrotestosterone
T37 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T38 1177-1198 DiseaseOrPhenotypicFeature denotes subcutaneous fat mass
T39 1211-1222 ChemicalEntity denotes cholesterol
T40 1255-1259 OrganismTaxon denotes mice
T41 1269-1298 DiseaseOrPhenotypicFeature denotes hepatocyte lipid accumulation
T42 1302-1316 CellLine denotes hepatoma cells
T43 1341-1345 GeneOrGeneProduct denotes mRNA
T44 1360-1373 GeneOrGeneProduct denotes hepatic genes
T45 1386-1391 ChemicalEntity denotes lipid
T46 1444-1446 GeneOrGeneProduct denotes AR
T47 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis
T48 1496-1507 OrganismTaxon denotes female mice
T49 1559-1575 DiseaseOrPhenotypicFeature denotes body composition
T50 1580-1596 DiseaseOrPhenotypicFeature denotes lipid metabolism

biored-valid-gemini-r-g

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 115-119 OrganismTaxon denotes mice
T6 121-130 ChemicalEntity denotes Androgens
T7 257-274 GeneOrGeneProduct denotes androgen receptor
T8 276-278 GeneOrGeneProduct denotes AR
T9 301-310 ChemicalEntity denotes androgens
T10 338-342 OrganismTaxon denotes mice
T11 383-387 OrganismTaxon denotes mice
T12 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T13 416-432 GeneOrGeneProduct denotes apolipoprotein E
T14 434-438 GeneOrGeneProduct denotes apoE
T15 569-571 GeneOrGeneProduct denotes AR
T16 732-744 ChemicalEntity denotes triglyceride
T17 761-768 GeneOrGeneProduct denotes insulin
T18 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia
T19 827-838 ChemicalEntity denotes cholesterol
T20 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T21 917-919 GeneOrGeneProduct denotes AR
T22 934-938 OrganismTaxon denotes mice
T23 957-961 OrganismTaxon denotes mice
T24 1050-1059 ChemicalEntity denotes androgens
T25 1098-1100 GeneOrGeneProduct denotes AR
T26 1109-1128 ChemicalEntity denotes dihydrotestosterone
T27 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T28 1211-1222 ChemicalEntity denotes cholesterol
T29 1255-1259 OrganismTaxon denotes mice
T30 1280-1285 ChemicalEntity denotes lipid
T31 1302-1310 DiseaseOrPhenotypicFeature denotes hepatoma
T32 1341-1345 GeneOrGeneProduct denotes mRNA
T33 1386-1391 ChemicalEntity denotes lipid

biored-valid-gpt-nr-ng

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 115-119 OrganismTaxon denotes mice
T6 121-130 ChemicalEntity denotes Androgens
T7 257-274 GeneOrGeneProduct denotes androgen receptor
T8 276-278 GeneOrGeneProduct denotes AR
T9 301-310 ChemicalEntity denotes androgens
T10 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis
T11 338-342 OrganismTaxon denotes mice
T12 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T13 416-432 GeneOrGeneProduct denotes apolipoprotein E
T14 434-438 GeneOrGeneProduct denotes apoE

biored-valid-gpt-r-ng

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 115-119 OrganismTaxon denotes mice
T6 121-130 ChemicalEntity denotes Androgens
T7 257-274 GeneOrGeneProduct denotes androgen receptor
T8 276-278 GeneOrGeneProduct denotes AR
T9 301-310 ChemicalEntity denotes androgens
T10 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis
T11 338-342 OrganismTaxon denotes mice
T12 364-382 SequenceVariant denotes AR-knockout (ARKO)
T13 383-387 OrganismTaxon denotes mice
T14 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T15 416-432 GeneOrGeneProduct denotes apolipoprotein E
T16 434-438 GeneOrGeneProduct denotes apoE
T17 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T18 569-573 SequenceVariant denotes ARKO
T19 600-614 SequenceVariant denotes apoE-deficient
T20 615-619 OrganismTaxon denotes mice
T21 632-639 GeneOrGeneProduct denotes AR gene
T22 732-744 ChemicalEntity denotes triglyceride
T23 753-780 DiseaseOrPhenotypicFeature denotes reduced insulin sensitivity
T24 795-819 DiseaseOrPhenotypicFeature denotes atherogenic dyslipidemia
T25 827-838 ChemicalEntity denotes cholesterol
T26 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T27 917-921 SequenceVariant denotes ARKO
T28 934-938 OrganismTaxon denotes mice
T29 1050-1059 ChemicalEntity denotes androgens
T30 1077-1079 GeneOrGeneProduct denotes AR
T31 1109-1128 ChemicalEntity denotes dihydrotestosterone
T32 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T33 1211-1222 ChemicalEntity denotes cholesterol
T34 1255-1259 OrganismTaxon denotes mice
T35 1302-1316 CellLine denotes hepatoma cells
T36 1444-1446 GeneOrGeneProduct denotes AR
T37 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis
T38 1503-1507 OrganismTaxon denotes mice

biored-valid-gpt-nr-g

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 108-119 OrganismTaxon denotes female mice
T6 121-130 ChemicalEntity denotes Androgens
T7 257-274 GeneOrGeneProduct denotes androgen receptor
T8 276-278 GeneOrGeneProduct denotes AR
T9 301-310 ChemicalEntity denotes androgens
T10 331-342 OrganismTaxon denotes female mice
T11 364-366 GeneOrGeneProduct denotes AR
T12 416-432 GeneOrGeneProduct denotes apolipoprotein E
T13 434-438 GeneOrGeneProduct denotes apoE
T14 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T15 600-604 GeneOrGeneProduct denotes apoE
T16 632-634 GeneOrGeneProduct denotes AR
T17 732-744 ChemicalEntity denotes triglyceride
T18 761-768 ChemicalEntity denotes insulin
T19 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia
T20 827-838 ChemicalEntity denotes cholesterol

biored-valid-gpt-r-g

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 115-119 OrganismTaxon denotes mice
T6 121-130 ChemicalEntity denotes Androgens
T7 257-274 GeneOrGeneProduct denotes androgen receptor
T8 276-278 GeneOrGeneProduct denotes AR
T9 301-310 ChemicalEntity denotes androgens
T10 338-342 OrganismTaxon denotes mice
T11 364-366 GeneOrGeneProduct denotes AR
T12 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T13 416-432 GeneOrGeneProduct denotes apolipoprotein E
T14 434-438 GeneOrGeneProduct denotes apoE
T15 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T16 600-604 GeneOrGeneProduct denotes apoE
T17 615-619 OrganismTaxon denotes mice
T18 632-634 GeneOrGeneProduct denotes AR
T19 732-744 ChemicalEntity denotes triglyceride
T20 753-780 DiseaseOrPhenotypicFeature denotes reduced insulin sensitivity
T21 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia
T22 827-838 ChemicalEntity denotes cholesterol
T23 934-938 OrganismTaxon denotes mice
T24 1050-1059 ChemicalEntity denotes androgens
T25 1077-1079 GeneOrGeneProduct denotes AR
T26 1109-1128 ChemicalEntity denotes dihydrotestosterone
T27 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T28 1211-1222 ChemicalEntity denotes cholesterol
T29 1255-1259 OrganismTaxon denotes mice
T30 1302-1310 DiseaseOrPhenotypicFeature denotes hepatoma
T31 1444-1446 GeneOrGeneProduct denotes AR
T32 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis
T33 1503-1507 OrganismTaxon denotes mice

biored-valid-gemini-nr-g

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 108-114 OrganismTaxon denotes female
T6 115-119 OrganismTaxon denotes mice
T7 121-130 ChemicalEntity denotes Androgens
T8 173-178 OrganismTaxon denotes males
T9 208-215 OrganismTaxon denotes females
T10 257-274 GeneOrGeneProduct denotes androgen receptor
T11 276-278 GeneOrGeneProduct denotes AR
T12 301-310 ChemicalEntity denotes androgens
T13 314-327 DiseaseOrPhenotypicFeature denotes atherogenesis
T14 331-337 OrganismTaxon denotes female
T15 338-342 OrganismTaxon denotes mice
T16 364-366 GeneOrGeneProduct denotes AR
T17 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T18 416-432 GeneOrGeneProduct denotes apolipoprotein E
T19 434-438 GeneOrGeneProduct denotes apoE
T20 569-571 GeneOrGeneProduct denotes AR
T21 600-604 GeneOrGeneProduct denotes apoE
T22 615-619 OrganismTaxon denotes mice
T23 632-634 GeneOrGeneProduct denotes AR
T24 795-819 DiseaseOrPhenotypicFeature denotes atherogenic dyslipidemia
T25 821-838 ChemicalEntity denotes serum cholesterol
T26 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T27 917-919 GeneOrGeneProduct denotes AR
T28 934-938 OrganismTaxon denotes mice
T29 957-961 OrganismTaxon denotes mice
T30 1050-1059 ChemicalEntity denotes androgens
T31 1098-1100 GeneOrGeneProduct denotes AR
T32 1109-1128 ChemicalEntity denotes dihydrotestosterone
T33 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T34 1255-1259 OrganismTaxon denotes mice
T35 1496-1502 OrganismTaxon denotes female

biored-valid-gpt-r-m

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 115-119 OrganismTaxon denotes mice
T6 121-130 ChemicalEntity denotes Androgens
T7 257-274 GeneOrGeneProduct denotes androgen receptor
T8 276-278 GeneOrGeneProduct denotes AR
T9 301-310 ChemicalEntity denotes androgens
T10 338-342 OrganismTaxon denotes mice
T11 364-366 GeneOrGeneProduct denotes AR
T12 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T13 416-432 GeneOrGeneProduct denotes apolipoprotein E
T14 434-438 GeneOrGeneProduct denotes apoE
T15 600-604 GeneOrGeneProduct denotes apoE
T16 615-619 OrganismTaxon denotes mice
T17 632-634 GeneOrGeneProduct denotes AR
T18 732-744 ChemicalEntity denotes triglyceride
T19 761-768 ChemicalEntity denotes insulin
T20 807-819 DiseaseOrPhenotypicFeature denotes dyslipidemia
T21 827-838 ChemicalEntity denotes cholesterol
T22 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T23 896-901 ChemicalEntity denotes lipid
T24 934-938 OrganismTaxon denotes mice
T25 1050-1059 ChemicalEntity denotes androgens
T26 1077-1079 GeneOrGeneProduct denotes AR
T27 1109-1128 ChemicalEntity denotes dihydrotestosterone
T28 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T29 1211-1222 ChemicalEntity denotes cholesterol
T30 1255-1259 OrganismTaxon denotes mice
T31 1280-1285 ChemicalEntity denotes lipid
T32 1386-1391 ChemicalEntity denotes lipid
T33 1444-1446 GeneOrGeneProduct denotes AR
T34 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis
T35 1503-1507 OrganismTaxon denotes mice
T36 1580-1585 ChemicalEntity denotes lipid

biored-valid-gemini-r-m

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 115-119 OrganismTaxon denotes mice
T6 121-130 ChemicalEntity denotes Androgens
T7 173-178 OrganismTaxon denotes males
T8 208-215 OrganismTaxon denotes females
T9 257-274 GeneOrGeneProduct denotes androgen receptor
T10 276-278 GeneOrGeneProduct denotes AR
T11 301-310 ChemicalEntity denotes androgens
T12 338-342 OrganismTaxon denotes mice
T13 364-375 SequenceVariant denotes AR-knockout
T14 377-381 SequenceVariant denotes ARKO
T15 394-415 DiseaseOrPhenotypicFeature denotes atherosclerosis-prone
T16 416-432 GeneOrGeneProduct denotes apolipoprotein E
T17 434-438 GeneOrGeneProduct denotes apoE
T18 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T19 569-573 SequenceVariant denotes ARKO
T20 574-581 OrganismTaxon denotes females
T21 600-614 DiseaseOrPhenotypicFeature denotes apoE-deficient
T22 615-619 OrganismTaxon denotes mice
T23 662-683 DiseaseOrPhenotypicFeature denotes increased body weight
T24 753-780 DiseaseOrPhenotypicFeature denotes reduced insulin sensitivity
T25 795-819 DiseaseOrPhenotypicFeature denotes atherogenic dyslipidemia
T26 821-838 ChemicalEntity denotes serum cholesterol
T27 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T28 917-921 SequenceVariant denotes ARKO
T29 934-938 OrganismTaxon denotes mice
T30 1050-1059 ChemicalEntity denotes androgens
T31 1077-1079 GeneOrGeneProduct denotes AR
T32 1098-1108 ChemicalEntity denotes AR agonist
T33 1109-1128 ChemicalEntity denotes dihydrotestosterone
T34 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T35 1177-1198 DiseaseOrPhenotypicFeature denotes subcutaneous fat mass
T36 1211-1222 ChemicalEntity denotes cholesterol
T37 1255-1259 OrganismTaxon denotes mice
T38 1269-1298 DiseaseOrPhenotypicFeature denotes hepatocyte lipid accumulation
T39 1302-1316 CellLine denotes hepatoma cells
T40 1341-1345 GeneOrGeneProduct denotes mRNA
T41 1444-1446 GeneOrGeneProduct denotes AR
T42 1477-1492 DiseaseOrPhenotypicFeature denotes atherosclerosis
T43 1503-1507 OrganismTaxon denotes mice

biored-valid-deepseek-r-m

Id Subject Object Predicate Lexical cue
T1 4-21 GeneOrGeneProduct denotes androgen receptor
T2 62-77 DiseaseOrPhenotypicFeature denotes atherosclerosis
T3 79-86 DiseaseOrPhenotypicFeature denotes obesity
T4 92-104 DiseaseOrPhenotypicFeature denotes dyslipidemia
T5 115-119 OrganismTaxon denotes mice
T6 121-130 ChemicalEntity denotes Androgens
T7 257-274 GeneOrGeneProduct denotes androgen receptor
T8 276-278 GeneOrGeneProduct denotes AR
T9 301-310 ChemicalEntity denotes androgens
T10 338-342 OrganismTaxon denotes mice
T11 347-351 GeneOrGeneProduct denotes gene
T12 367-375 GeneOrGeneProduct denotes knockout
T13 377-381 GeneOrGeneProduct denotes ARKO
T14 383-387 OrganismTaxon denotes mice
T15 394-409 DiseaseOrPhenotypicFeature denotes atherosclerosis
T16 416-432 GeneOrGeneProduct denotes apolipoprotein E
T17 434-438 GeneOrGeneProduct denotes apoE
T18 440-449 DiseaseOrPhenotypicFeature denotes deficient
T19 527-542 DiseaseOrPhenotypicFeature denotes atherosclerosis
T20 569-572 GeneOrGeneProduct denotes ARK
T21 572-573 GeneOrGeneProduct denotes O
T22 574-581 OrganismTaxon denotes females
T23 600-614 DiseaseOrPhenotypicFeature denotes apoE-deficient
T24 615-619 OrganismTaxon denotes mice
T25 672-683 DiseaseOrPhenotypicFeature denotes body weight
T26 692-711 DiseaseOrPhenotypicFeature denotes body fat percentage
T27 724-744 ChemicalEntity denotes hepatic triglyceride
T28 761-780 DiseaseOrPhenotypicFeature denotes insulin sensitivity
T29 795-819 DiseaseOrPhenotypicFeature denotes atherogenic dyslipidemia
T30 821-838 ChemicalEntity denotes serum cholesterol
T31 862-877 DiseaseOrPhenotypicFeature denotes atherosclerosis
T32 896-908 ChemicalEntity denotes lipid levels
T33 917-919 GeneOrGeneProduct denotes AR
T34 934-938 OrganismTaxon denotes mice
T35 957-961 OrganismTaxon denotes mice
T36 1050-1059 ChemicalEntity denotes androgens
T37 1098-1100 GeneOrGeneProduct denotes AR
T38 1109-1128 ChemicalEntity denotes dihydrotestosterone
T39 1137-1152 DiseaseOrPhenotypicFeature denotes atherosclerosis
T40 1177-1198 DiseaseOrPhenotypicFeature denotes subcutaneous fat mass
T41 1255-1259 OrganismTaxon denotes mice
T42 1269-1298 DiseaseOrPhenotypicFeature denotes hepatocyte lipid accumulation
T43 1302-1316 CellLine denotes hepatoma cells
T44 1341-1345 GeneOrGeneProduct denotes mRNA
T45 1386-1403 ChemicalEntity denotes lipid homeostasis